You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 22, 2024

ADVIL DUAL ACTION WITH ACETAMINOPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Advil Dual Action With Acetaminophen, and when can generic versions of Advil Dual Action With Acetaminophen launch?

Advil Dual Action With Acetaminophen is a drug marketed by Haleon Us Holdings and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.

This drug has twelve patent family members in eleven countries.

The generic ingredient in ADVIL DUAL ACTION WITH ACETAMINOPHEN is acetaminophen; ibuprofen. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; ibuprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Advil Dual Action With Acetaminophen

A generic version of ADVIL DUAL ACTION WITH ACETAMINOPHEN was approved as acetaminophen; ibuprofen by L PERRIGO CO on February 28th, 2023.

  Sign Up

Summary for ADVIL DUAL ACTION WITH ACETAMINOPHEN
International Patents:12
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 3
Clinical Trials: 83
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in ADVIL DUAL ACTION WITH ACETAMINOPHEN?ADVIL DUAL ACTION WITH ACETAMINOPHEN excipients list
DailyMed Link:ADVIL DUAL ACTION WITH ACETAMINOPHEN at DailyMed
Drug patent expirations by year for ADVIL DUAL ACTION WITH ACETAMINOPHEN
Paragraph IV (Patent) Challenges for ADVIL DUAL ACTION WITH ACETAMINOPHEN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ADVIL DUAL ACTION WITH ACETAMINOPHEN Tablets acetaminophen; ibuprofen 125 mg/250 mg 211733 2 2024-03-28

US Patents and Regulatory Information for ADVIL DUAL ACTION WITH ACETAMINOPHEN

ADVIL DUAL ACTION WITH ACETAMINOPHEN is protected by one US patents.

Patents protecting ADVIL DUAL ACTION WITH ACETAMINOPHEN


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings ADVIL DUAL ACTION WITH ACETAMINOPHEN acetaminophen; ibuprofen TABLET;ORAL 211733-001 Feb 28, 2020 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ADVIL DUAL ACTION WITH ACETAMINOPHEN

See the table below for patents covering ADVIL DUAL ACTION WITH ACETAMINOPHEN around the world.

Country Patent Number Title Estimated Expiration
Japan 2022540348 新規なイブプロフェン及びアセトアミノフェン組成物 ⤷  Sign Up
Australia 2024200875 NOVEL IBUPROFEN AND ACETAMINOPHEN COMPOSITION ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2020263947 ⤷  Sign Up
Colombia 2021017722 Composición novedosa de ibuprofeno y acetaminofeno ⤷  Sign Up
European Patent Office 3989944 NOUVELLE COMPOSITION D'IBUPROFÈNE ET D'ACÉTAMINOPHÈNE (NOVEL IBUPROFEN AND ACETAMINOPHEN COMPOSITION) ⤷  Sign Up
Mexico 2021016089 COMPOSICIÓN NOVEDOSA DE IBUPROFENO Y ACETAMINOFENO. (NOVEL IBUPROFEN AND ACETAMINOPHEN COMPOSITION.) ⤷  Sign Up
Australia 2020301401 Novel ibuprofen and acetaminophen composition ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.